Insider Trading activities of Dicerna Pharmaceuticals Inc (DRNA)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dicerna Pharmaceuticals Inc (DRNA) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dicerna Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Dicerna Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is DRNA. The reporting company's CIK number is 1399529.
The total value of stock buying since 2005 is $38,336,508.
The total value of stock sales since 2005 is $215,200,890.
The total value of stock option exercises since 2005 is $2,333,607.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Dicerna Pharmaceuticals Inc (DRNA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2020-01 0 $0 52,329 $1,115,531 52,329 $156,397
2019-12 0 $0 1,920,438 $47,392,372 229,232 $823,084
2019-11 0 $0 4,158,055 $95,186,908 85,000 $341,450
2019-10 0 $0 27,500 $495,000 32,404 $136,196
2019-08 0 $0 14,680 $191,838 0 $0
2019-05 0 $0 1,600,000 $20,000,000 0 $0
2019-04 0 $0 15,000 $225,000 15,000 $51,300
2018-11 0 $0 524,575 $7,048,379 0 $0
2018-10 0 $0 374,725 $5,193,072 0 $0
2018-09 0 $0 2,301 $40,267 2,301 $7,869
2018-08 0 $0 38,341 $613,456 14,680 $50,205
2018-06 0 $0 0 $0 21,197 $148,379
2018-05 0 $0 19,669 $295,035 10,000 $34,200
2018-04 0 $0 8,965 $116,545 0 $0
2018-03 0 $0 1,035 $13,455 0 $0
2018-01 0 $0 0 $0 360 $1,231
2017-12 285,000 $1,995,000 0 $0 13,745,272 $0
2016-11 33,100 $122,643 23,766 $83,656 0 $0
2016-05 5,000 $16,365 0 $0 0 $0
2016-02 0 $0 0 $0 34,722 $118,749
2015-02 0 $0 37,532 $976,582 0 $0
2014-12 0 $0 0 $0 2,500 $8,550
2014-11 0 $0 536,129 $5,627,405 0 $0
2014-10 0 $0 117,778 $1,277,613 0 $0
2014-03 0 $0 786,138 $29,308,776 0 $0
2014-02 2,400,000 $36,000,000 0 $0 0 $0
2014-01 13,500 $202,500 0 $0 123,794 $421,343
2013-11 0 $0 0 $0 10,133 $34,654

Table 2. Detailed insider stock purchases, sales, and option exercises of Dicerna Pharmaceuticals Inc insiders (DRNA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2020-01-17 Green John B (Chief Financial Officer) Sale 47,969 21.27 1,020,156
2020-01-17 Green John B (Chief Financial Officer) Option Ex 47,969 2.97 142,467
2020-01-02 Weissman James B (EVP & Chief Operating Officer) Sale 4,360 21.88 95,375
2020-01-02 Weissman James B (EVP & Chief Operating Officer) Option Ex 4,360 3.19 13,930
2019-12-31 Brown Bob D (See Remarks) Sale 23,882 22.00 525,404
2019-12-31 Brown Bob D (See Remarks) Option Ex 33,882 3.19 108,252
2019-12-30 Brown Bob D (See Remarks) Sale 45,612 21.93 1,000,042
2019-12-30 Brown Bob D (See Remarks) Option Ex 26,272 3.19 83,938
2019-12-26 Rosskamp Ralf (Chief Medical Officer) Sale 20,000 22.69 453,760
2019-12-26 Rosskamp Ralf (Chief Medical Officer) Option Ex 20,000 2.91 58,200
2019-12-18 Weissman James B (EVP & Chief Operating Officer) Option Ex 11,001 9.09 99,999
2019-12-18 Fambrough Douglas (Chief Executive Officer) Sale 80,000 26.46 2,116,880
2019-12-18 Fambrough Douglas (Chief Executive Officer) Option Ex 80,000 3.42 273,600
2019-12-17 Fambrough Douglas (Chief Executive Officer) Sale 59,021 26.54 1,566,358
2019-12-11 Green John B (Chief Financial Officer) Option Ex 8,000 5.45 43,600
2019-12-04 Koppel Adam (Director) Sale 1,500,000 24.68 37,020,000
2019-12-02 Weissman James B (EVP & Chief Operating Officer) Sale 20,000 26.00 520,000
2019-12-02 Weissman James B (EVP & Chief Operating Officer) Option Ex 20,000 2.97 59,400
2019-12-02 Kolchinsky Peter Sale 137,176 24.98 3,427,205
2019-11-29 Kolchinsky Peter Sale 138,000 24.21 3,341,670
2019-11-27 Kolchinsky Peter Sale 368,700 24.04 8,864,654
2019-11-26 Kolchinsky Peter Sale 239,700 23.59 5,653,564
2019-11-25 Kolchinsky Peter Sale 361,200 24.06 8,689,749
2019-11-25 Green John B (Chief Financial Officer) Sale 12,500 24.95 311,875
2019-11-25 Green John B (Chief Financial Officer) Option Ex 12,500 5.45 68,125
2019-11-22 Kolchinsky Peter Sale 197,700 22.52 4,451,413
2019-11-21 Kolchinsky Peter Sale 351,505 22.98 8,076,881
2019-11-20 Kolchinsky Peter Sale 265,505 22.93 6,088,826
2019-11-19 Weissman James B (EVP & Chief Operating Officer) Sale 20,000 24.00 480,000
2019-11-19 Weissman James B (EVP & Chief Operating Officer) Option Ex 20,000 3.42 68,400
2019-11-19 Koppel Adam (Director) Sale 1,750,000 22.03 38,552,500
2019-11-19 Kolchinsky Peter Sale 397,183 23.92 9,501,411
2019-11-18 Weissman James B (EVP & Chief Operating Officer) Sale 20,000 22.00 440,000
2019-11-18 Weissman James B (EVP & Chief Operating Officer) Option Ex 20,000 3.42 68,400
2019-11-18 Green John B (Chief Financial Officer) Sale 12,500 21.05 263,125
2019-11-18 Green John B (Chief Financial Officer) Option Ex 12,500 5.45 68,125
2019-11-14 Weissman James B (EVP & Chief Operating Officer) Sale 20,000 20.00 400,000
2019-11-14 Weissman James B (EVP & Chief Operating Officer) Option Ex 20,000 3.42 68,400
2019-11-14 Green John B (Chief Financial Officer) Sale 3,562 20.00 71,240
2019-10-31 Weissman James B (EVP & Chief Operating Officer) Sale 15,000 18.00 270,000
2019-10-31 Weissman James B (EVP & Chief Operating Officer) Option Ex 15,000 3.42 51,300
2019-10-31 Green John B (Chief Financial Officer) Sale 12,500 18.00 225,000
2019-10-31 Green John B (Chief Financial Officer) Option Ex 12,500 5.45 68,125
2019-10-18 Weissman James B (EVP & Chief Operating Officer) Option Ex 4,904 3.42 16,771
2019-08-23 Weissman James B (Chief Business Officer) Sale 14,680 13.07 191,838
2019-05-29 Koppel Adam (Director) Sale 1,600,000 12.50 20,000,000
2019-04-02 Weissman James B (Chief Business Officer) Sale 15,000 15.00 225,000
2019-04-02 Weissman James B (Chief Business Officer) Option Ex 15,000 3.42 51,300
2018-11-06 Halak Brian K (Director) Sale 104,328 13.67 1,426,163
2018-11-05 Halak Brian K (Director) Sale 39,901 12.98 517,914
2018-11-02 Halak Brian K (Director) Sale 190,771 13.47 2,569,685
2018-11-01 Halak Brian K (Director) Sale 189,575 13.37 2,534,617
2018-10-31 Halak Brian K (Director) Sale 129,629 13.60 1,762,954
2018-10-30 Halak Brian K (Director) Sale 245,096 13.99 3,430,118
2018-09-05 Weissman James B (Chief Business Officer) Sale 2,301 17.50 40,267
2018-09-05 Weissman James B (Chief Business Officer) Option Ex 2,301 3.42 7,869
2018-08-17 Weissman James B (Chief Business Officer) Option Ex 14,680 3.42 50,205
2018-08-15 Langer Dennis Sale 38,341 16.00 613,456
2018-06-07 Halak Brian K (Director) Option Ex 21,197 7.00 148,379
2018-05-09 Weissman James B (Chief Business Officer) Sale 10,000 15.00 150,000
2018-05-09 Weissman James B (Chief Business Officer) Option Ex 10,000 3.42 34,200
2018-05-09 Brown Bob D (Chief Scientific Officer) Sale 9,669 15.00 145,035
2018-04-20 Weissman James B (Chief Business Officer) Sale 8,965 13.00 116,545
2018-03-19 Weissman James B (Chief Business Officer) Sale 1,035 13.00 13,455
2018-01-26 Langer Dennis (Director) Option Ex 360 3.42 1,231
2017-12-18 Koppel Adam (Director) Buy 285,000 7.00 1,995,000
2017-12-18 Koppel Adam (Director) Option Ex 8,454,388 .00 0
2017-12-18 Kolchinsky Peter Option Ex 2,645,442 .00 0
2017-12-18 Ra Capital Healthcare Fund Lp Option Ex 2,645,442 .00 0
2016-11-16 Langer Dennis (Director) Sale 23,766 3.52 83,656
2016-11-15 Fambrough Douglas (Chief Executive Officer) Buy 16,500 3.63 59,895
2016-11-14 Fambrough Douglas (Chief Executive Officer) Buy 16,600 3.78 62,748
2016-05-12 Weissman James B (Chief Business Officer) Buy 5,000 3.27 16,365
2016-02-03 Langer Dennis (Director) Option Ex 34,722 3.42 118,749
2015-02-20 Kaneko Yasunori (Other) Sale 37,532 26.02 976,582
2014-12-17 Fambrough Douglas (Chief Executive Officer) Option Ex 2,500 3.42 8,550
2014-11-25 Deerfield Private Design International Ii, L.p. Sale 121,965 11.50 1,402,597
2014-11-24 Deerfield Private Design International Ii, L.p. Sale 100,000 11.54 1,154,500
2014-11-21 Deerfield Private Design International Ii, L.p. Sale 100,000 11.00 1,100,000
2014-11-07 Deerfield Private Design International Ii, L.p. Sale 214,164 9.20 1,970,308
2014-10-15 Deerfield Private Design International Ii, L.p. Sale 51,449 10.01 515,004
2014-10-14 Deerfield Private Design International Ii, L.p. Sale 36,115 11.02 397,987
2014-10-10 Deerfield Private Design International Ii, L.p. Sale 30,214 12.07 364,622
2014-03-18 Brookside Capital Trading Fund, L.p. (10% Owner) Sale 264,937 38.19 10,116,619
2014-03-17 Brookside Capital Trading Fund, L.p. (10% Owner) Sale 9,301 36.50 339,486
2014-03-14 Brookside Capital Trading Fund, L.p. (10% Owner) Sale 250,400 35.41 8,867,916
2014-03-12 Brookside Capital Trading Fund, L.p. (10% Owner) Sale 1,500 37.77 56,655
2014-03-11 Brookside Capital Trading Fund, L.p. (10% Owner) Sale 260,000 38.19 9,928,100
2014-02-04 Deerfield Private Design International Ii, Ltd. Buy 1,000,000 15.00 15,000,000
2014-02-04 Ra Capital Healthcare Fund Lp Buy 1,000,000 15.00 15,000,000
2014-02-04 Kaneko Yasunori (10% Owner) Buy 200,000 15.00 3,000,000
2014-02-04 Hoffman Stephen J (Director) Buy 200,000 15.00 3,000,000
2014-01-29 Weissman James B (Chief Business Officer) Buy 1,000 15.00 15,000
2014-01-29 Fambrough Douglas (Chief Executive Officer) Buy 5,000 15.00 75,000
2014-01-29 Madden David (Director) Buy 7,500 15.00 112,500
2014-01-27 Weissman James B (Chief Business Officer) Option Ex 11,283 3.24 36,556
2014-01-24 Madden David (Director) Option Ex 112,511 3.42 384,787
2013-11-11 Fambrough Douglas (Chief Executive Officer) Option Ex 9,300 3.42 31,806
2013-11-05 Weissman James B (Chief Business Officer) Option Ex 833 3.42 2,848

Insider trading activities including stock purchases, stock sales, and option exercises of DRNA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dicerna Pharmaceuticals Inc (symbol DRNA, CIK number 1399529) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month